StockData
Moderna, Inc. logo

Moderna, Inc. (MRNA) stock

MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30537% above fair value
$206.80−8.47 (-3.93%)

Close on Nov 17, 2026Market cap $82.56BP/E –Yield –

Moderna r&d expenses

Research and development expenses are spending on new products and technology.

Moderna's R&D Expenses for the twelve months ending Jun 30, 2026 was $2.88B, down 24.6% year over year. For fiscal 2025 it was $3.13B, down 31.1% from the year before. The highest annual figure on record is $4.85B in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.13B-31.1%
FY2024Dec 31, 2024$4.54B-6.2%
FY2023Dec 31, 2023$4.85B+47.0%
FY2022Dec 31, 2022$3.30B+65.5%
FY2021Dec 31, 2021$1.99B+45.3%
FY2020Dec 31, 2020$1.37B+176.2%
FY2019Dec 31, 2019$496.00M+9.2%
FY2018Dec 31, 2018$454.08M+10.6%
FY2017Dec 31, 2017$410.46M+49.4%
FY2016Dec 31, 2016$274.72M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$651.00M-7.0%
Q1 FY2026Mar 31, 2026$649.00M-24.2%
Q4 FY2025Dec 31, 2025$775.00M-30.9%
Q3 FY2025Sep 30, 2025$801.00M-29.6%
Q2 FY2025Jun 30, 2025$700.00M-42.7%
Q1 FY2025Mar 31, 2025$856.00M-19.5%
Q4 FY2024Dec 31, 2024$1.12B-20.2%
Q3 FY2024Sep 30, 2024$1.14B-2.0%
Q2 FY2024Jun 30, 2024$1.22B+6.4%
Q1 FY2024Mar 31, 2024$1.06B-6.0%
Q4 FY2023Dec 31, 2023$1.41B+16.1%
Q3 FY2023Sep 30, 2023$1.16B+41.5%
Q2 FY2023Jun 30, 2023$1.15B+61.7%
Q1 FY2023Mar 31, 2023$1.13B+104.2%
Q4 FY2022Dec 31, 2022$1.21B+86.9%
Q3 FY2022Sep 30, 2022$820.00M+57.4%
Q2 FY2022Jun 30, 2022$710.00M+68.6%
Q1 FY2022Mar 31, 2022$554.00M+38.2%
Q4 FY2021Dec 31, 2021$648.00M-14.6%
Q3 FY2021Sep 30, 2021$521.00M+51.5%
Q2 FY2021Jun 30, 2021$421.00M+177.0%
Q1 FY2021Mar 31, 2021$401.00M+248.7%
Q4 FY2020Dec 31, 2020$759.00M+545.2%
Q3 FY2020Sep 30, 2020$344.00M+187.5%
Q2 FY2020Jun 30, 2020$152.00M+18.5%
Q1 FY2020Mar 31, 2020$115.00M-11.8%
Q4 FY2019Dec 31, 2019$117.65M-21.8%
Q3 FY2019Sep 30, 2019$119.64M+9.7%
Q2 FY2019Jun 30, 2019$128.31M+22.8%
Q1 FY2019Mar 31, 2019$130.41M+44.7%
Q4 FY2018Dec 31, 2018$150.43M–
Q3 FY2018Sep 30, 2018$109.05M–
Q2 FY2018Jun 30, 2018$104.48M–
Q1 FY2018Mar 31, 2018$90.12M–

More Moderna figures

See a number that looks wrong?